Centogene up on launch of at-home COVID-19 test kit in Germany

Crown LiquidationCo NV in liquidatie

23/07/2020 12:43

** U.S.-listed shares of Germany based diagnostic and pharma
co  CNTG.O  jump ~26.7% to $15.19 premarket
    ** Co said its at-home COVID-19 test kit, CentoKit-19, is
now available online for purchase in Germany  urn:newsml:reuters.com:*:nGNX9cN1H5
    ** Test detects an infection of SARS-CoV-2 by detecting
specific RNA molecules that originate from genome of
disease-causing coronavirus
    ** Kit includes a swab sampling kit, CentoSwab, which was
launched in April along with collection tube, labelled and
prepaid return boxes, UN3373 plastic bag, and a package insert
    ** Shares rose ~9% on July 2 after U.S. FDA granted
emergency use authorization to co's COVID-19 molecular
diagnostic test  urn:newsml:reuters.com:*:nL4N2E92WK
    ** U.S.-listed shares up ~18.9% this year, up to last close

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))